Matt Shaulis joined BeOne in 2024 as General Manager of North America.
Mr. Shaulis joined BeOne from Hansa Biopharma, where he served as Chief Commercial Officer and U.S. President. Prior to joining Hansa, he was President of Pfizer Inflammation and Immunology for International Developed Markets and previously was Pfizer’s President of North America Oncology. He joined Pfizer from Cephalon (acquired by Teva Pharmaceuticals), where he was Vice President and Global Therapeutic Area Lead, Multiple Sclerosis, with prior experience in senior sales and marketing roles with Cephalon, Johnson & Johnson and Schering-Plough.
Mr. Shaulis earned a B.S. from The Pennsylvania State University and an MBA from the Fuqua School of Business at Duke University.